AI technology platform Excelera entered into a definitive business combination agreement with the special purpose acquisition company, Future Health ESG.
The transaction values the combined company at ~$459M.
The merger is expected to deliver net proceeds of at least $105M, and up to $282M.
The boards of the 2 companies have unanimously approved the transaction, expected to close in H2.
Upon the completion of the transaction, the combined company is expected to operate as Excelera Health under the ticker symbol XLRA.
Cantor Fitzgerald & Co., BTIG, LLC and Roth Capital Partners, LLC are capital markets advisors to Future Health, while Buchanan Ingersoll & Rooney PC is legal counsel to Excelera, and McDermott Will & Emery LLP is legal counsel to Future Health.